does the novel therapeutic alln rescue the phenotype of cardiomyocytes that have mutated kdr channels lqts2 such that they are normal how might this therapeutic work could this therapeutic be used to treat long qt syndrome for all long qt suffere


I need to write a claim, support it with evidence and then write an explanation for the question above.

I attached the graph and all the information in the picture